Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 45, 2015 - Issue 12
396
Views
19
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Disposition, metabolism and mass balance of delafloxacin in healthy human volunteers following intravenous administration

, , , , , , & show all
Pages 1054-1062 | Received 24 Feb 2015, Accepted 16 Apr 2015, Published online: 19 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Silvia Gómez-Zorrilla, Elena Sendra & Juan P. Horcajada. (2022) A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia. Expert Review of Clinical Pharmacology 15:6, pages 671-688.
Read now
Matteo Bassetti, Monica Melchio & Daniele Roberto Giacobbe. (2022) Delafloxacin for the treatment of adult patients with community-acquired bacterial pneumonia. Expert Review of Anti-infective Therapy 20:5, pages 649-656.
Read now
Georgios L. Voulgaris, Maria L. Voulgari & Matthew E. Falagas. (2019) Developments on antibiotics for multidrug resistant bacterial Gram-negative infections. Expert Review of Anti-infective Therapy 17:6, pages 387-401.
Read now
Elda Righi, Alessia Carnelutti, Antonio Vena & Matteo Bassetti. (2018) Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin. Infection and Drug Resistance 11, pages 479-488.
Read now
Matteo Bassetti, Davide Pecori, Piergiorgio Cojutti, Elda Righi & Federico Pea. (2017) Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections. Expert Opinion on Drug Metabolism & Toxicology 13:11, pages 1193-1200.
Read now

Articles from other publishers (14)

Adrien Turban, François Guérin, Aurélien Dinh & Vincent Cattoir. (2023) Updated Review on Clinically-Relevant Properties of Delafloxacin. Antibiotics 12:8, pages 1241.
Crossref
Simon G. Wong & Shuguang Ma. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development 137 174 .
L. J. Scott. (2020) Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections. Drugs 80:12, pages 1247-1258.
Crossref
Jennifer Shiu, Grace Ting & Tony KL Kiang. (2018) Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin. European Journal of Drug Metabolism and Pharmacokinetics 44:3, pages 305-317.
Crossref
. 2019. Demystifying Drug Dosing in Renal Dysfunction. Demystifying Drug Dosing in Renal Dysfunction 15 86 .
Paul M Tulkens, Françoise Van Bambeke & Stephen H Zinner. (2019) Profile of a Novel Anionic Fluoroquinolone—Delafloxacin. Clinical Infectious Diseases 68:Supplement_3, pages S213-S222.
Crossref
忠秋 郭. (2019) Delafloxacin: A Novel Fluoroquinolones Broad-Spectrum Antibacterial. Pharmacy Information 08:01, pages 9-15.
Crossref
Matteo Bassetti, Elda Righi, Davide Pecori & Glenn Tillotson. (2018) Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineering. Future Microbiology 13:10, pages 1081-1094.
Crossref
Randall Hoover, Harry AlcornJrJr, Laura Lawrence, Susan K. Paulson, Megan Quintas & Sue K. Cammarata. (2018) Pharmacokinetics of Intravenous Delafloxacin in Patients With End-Stage Renal Disease. The Journal of Clinical Pharmacology 58:7, pages 913-919.
Crossref
Bryan T Mogle, Jeffrey M Steele, Stephen J Thomas, KarenBeth H Bohan & Wesley D Kufel. (2018) Clinical review of delafloxacin: a novel anionic fluoroquinolone. Journal of Antimicrobial Chemotherapy 73:6, pages 1439-1451.
Crossref
Sarah C. J. Jorgensen, Nicholas J. Mercuro, Susan L. Davis & Michael J. Rybak. (2018) Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties. Infectious Diseases and Therapy 7:2, pages 197-217.
Crossref
Randall K. Hoover, Harry AlcornJr.Jr., Laura Lawrence, Susan K. Paulson, Megan Quintas & Sue K. Cammarata. (2017) Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function. The Journal of Clinical Pharmacology 58:4, pages 514-521.
Crossref
Randall Hoover, Thomas C. Marbury, Richard A. Preston, Megan Quintas, Laura E. Lawrence, Susan K. Paulson, David R. Luke & Sue K. Cammarata. (2017) Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment. The Journal of Clinical Pharmacology 57:3, pages 328-335.
Crossref
Randall Hoover, Thomas Hunt, Michael Benedict, Susan K. Paulson, Laura Lawrence, Sue Cammarata & Eugene Sun. (2016) Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers. Clinical Therapeutics 38:1, pages 53-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.